Nebulised 3% hypertonic saline versus 0.9% saline for treating patients hospitalised with acute bronchiolitis: protocol for a randomised, double-blind, multicentre trial
Introduction Bronchiolitis is an acute viral infection of the lower respiratory tract. It is most commonly caused by respiratory syncytial virus. Being a common reason for hospitalisation, it affects 13–17% of all hospitalised children younger than 2 years. Only supportive therapy, including suction...
Saved in:
Main Authors: | Sara Szupieńko, Aleksandra Buczek, Henryk Szymański |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/13/11/e080182.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparing Treatment with Nebulized 3% Hypertonic Saline Versus Nebulized 0.9% Saline In Patients With Acute Bronchiolitis: A Double-Blind Randomized Controlled Trial
by: Uzma Abid, et al.
Published: (2024-03-01) -
Median Preoptic Nucleus Mediates the Cardiovascular Recovery Induced by Hypertonic Saline in Hemorrhagic Shock
by: Nathalia Oda Amaral, et al.
Published: (2014-01-01) -
Optimal Dose and Concentration of Hypertonic Saline in Traumatic Brain Injury: A Systematic Review
by: Martin SUSANTO, et al.
Published: (2022-06-01) -
Symptomatic Abdominal Simple Cysts: Is Percutaneous Sclerotherapy with Hypertonic Saline and Bleomycin a Treatment Option?
by: V. D. Souftas, et al.
Published: (2015-01-01) -
The effectiveness of hyaluronic acid in reducing adverse effects associated with inhaled hypertonic saline therapy in patients with cystic fibrosis: A systematic review and meta-analysis
by: Sana Arshid, et al.
Published: (2023-10-01)